Home › Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...
 

Keywords :   


Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...

2014-11-04 04:36:32| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- --Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTATM , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.

Tags: european swedish announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Boeing boss's $33m pay package approved
17.05Urban Decay Renews Sponsorship Agreement with the Los Angeles Sparks
17.05Bank of England plans expansion of Leeds base
17.05Bank of England plans expansion of Leeds base
Consumer Goods and Services »
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
More »